Johnson & Johnson must pay $260M to an Oregon woman who said she got mesothelioma from inhaling the company’s talc powder, a jury found on Monday, reports Brendan Pierson of Reuters. The jury’s award includes $60M in compensatory damages and $200M in punitive damages, and includes damages for both the plaintiff and her husband. Erik Haas, J&J’s worldwide vice president of litigation, said in a statement that the verdict “is irreconcilable with the decades of independent scientific evaluations confirming talc is safe, does not contain asbestos, and does not cause cancer.” He said the company would appeal and was confident it would get the verdict reversed.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Sarepta to replace ShockWave Medical in S&P 400 at open on 6/3
- Johnson & Johnson completes Shockwave acquisition, sees EPS dilution
- Vanda Pharma completes transfer of FDA Marketing Authorization for Ponvory
- PayPal upgraded, UiPath downgraded: Wall Street’s top analyst calls
- Johnson & Johnson reinstated with a Neutral at Goldman Sachs